BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7599772)

  • 1. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival prognosis and clinicopathological features of the lymph nodes along the left gastric artery in gastric cancer: implications for D2 lymphadenectomy.
    Chen JH; Cai SR; Zhai ET; Chen SL; Wu KM; Song W; He YL
    Int J Clin Exp Pathol; 2015; 8(11):14365-73. PubMed ID: 26823752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).
    Xie D; Shen J; Liu L; Cao B; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Gong J
    Br J Surg; 2024 May; 111(5):. PubMed ID: 38713611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of total number of harvested lymph nodes on survival outcomes after curative resection for gastric adenocarcinoma: findings from an eastern high-volume gastric cancer center.
    Macalindong SS; Kim KH; Nam BH; Ryu KW; Kubo N; Kim JY; Eom BW; Yoon HM; Kook MC; Choi IJ; Kim YW
    BMC Cancer; 2018 Jan; 18(1):73. PubMed ID: 29329569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphadenectomy with Optimum of 29 Lymph Nodes Retrieved Associated with Improved Survival in Advanced Gastric Cancer: A 25,000-Patient International Database Study.
    Woo Y; Goldner B; Ituarte P; Lee B; Melstrom L; Son T; Noh SH; Fong Y; Hyung WJ
    J Am Coll Surg; 2017 Apr; 224(4):546-555. PubMed ID: 28017807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of hepatoduodenal lymph node metastasis in gastric cancer.
    Imamura T; Komatsu S; Ichikawa D; Kosuga T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Otsuji E
    World J Gastroenterol; 2015 Oct; 21(38):10866-73. PubMed ID: 26478677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term and long-term risk factors in gastric cancer.
    Verlato G; Marrelli D; Accordini S; Bencivenga M; Di Leo A; Marchet A; Petrioli R; Zoppini G; Muggeo M; Roviello F; de Manzoni G
    World J Gastroenterol; 2015 Jun; 21(21):6434-43. PubMed ID: 26074682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenging the Dogma: Stage migration or negative lymph nodes, which of them is the main player on gastric cancer prognosis?
    Costa PMD; Antunes C; Lages P; Rodrigues J; Peyroteo M; Onofre S; Lara Santos L
    Eur J Surg Oncol; 2024 Jun; 50(6):108318. PubMed ID: 38626587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premature mortality for patients after completely resected early adenocarcinoma of the esophagus or stomach.
    Bollschweiler E; Hölscher AH; Markar SR; Alakus H; Drebber U; Mönig SP; Plum PS
    Cancer Med; 2024 May; 13(10):e7223. PubMed ID: 38778711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal lymph node dissection for gastric cancer: a narrative review.
    Nico R; Veziant J; Chau A; Eveno C; Piessen G
    World J Surg Oncol; 2024 Apr; 22(1):108. PubMed ID: 38654357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D1 versus D2 lymphadenectomy for gastric cancer.
    Schmidt B; Yoon SS
    J Surg Oncol; 2013 Mar; 107(3):259-64. PubMed ID: 22513454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of Post-Operative Morbidity Severity Score After Potentially Curative D2 Gastrectomy for Carcinoma.
    Powell A; Coxon AH; Patel N; Chan D; Christian A; Lewis W
    J Gastrointest Surg; 2018 Sep; 22(9):1516-1527. PubMed ID: 29766446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoprotein 130 is associated with adverse postoperative clinical outcomes of patients with late-stage non-metastatic gastric cancer.
    Cao Y; Zhang H; Liu H; Lin C; Li R; Wu S; He H; Li H; Xu J
    Sci Rep; 2016 Dec; 6():38364. PubMed ID: 27917904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated brachioradialis metastasis of gastric adenocarcinoma after R0 resection.
    Jacob E; Smucker L; Crouse R; Allard-Picou A
    World J Surg Oncol; 2021 Mar; 19(1):83. PubMed ID: 33743738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal extent of lymph node dissection for high-risk gastric cancer stratified by a national clinical database risk calculator.
    Kuroda K; Miki Y; Kasashima H; Yoshii M; Fukuoka T; Tamura T; Shibutani M; Toyokawa T; Lee S; Maeda K
    World J Surg; 2024 May; 48(5):1198-1208. PubMed ID: 38391091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical resection of synchronous liver metastases in gastric cancer patients. A propensity score-matched study.
    Jagric T; Horvat M
    Radiol Oncol; 2020 Nov; 55(1):57-65. PubMed ID: 33885239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive Lymph Node Dissection Improves Survival among American Patients with Gastric Adenocarcinoma Treated Surgically: Analysis of the National Cancer Database.
    Naffouje SA; Salti GI
    J Gastric Cancer; 2017 Dec; 17(4):319-330. PubMed ID: 29302372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrectomy with D2 Lymphadenectomy for Carcinoma of the Stomach in a Stand-alone Cancer Centre in Rural India.
    Pareekutty NM; Kadam S; Ankalkoti B; Balasubramanian S; Anilkumar B
    Indian J Surg Oncol; 2020 Jun; 11(2):256-262. PubMed ID: 32523272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Segmental and extended resections provide comparable survival for clinically node-negative splenic flexure cancer: a propensity score-matched analysis of the National Cancer Database.
    Freund MR; Horesh N; Emile SH; Garoufalia Z; Gefen R; Wexner SD
    Tech Coloproctol; 2023 Nov; 27(11):1073-1081. PubMed ID: 37071308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathologic response in patients with curative resection with D2 dissection following neoadjuvant treatment for locally advanced gastric and esophagogastric junction adenocarcinoma.
    Alemdar A; Duman MG; Sengiz Erhan S; Sasako M
    Eur J Surg Oncol; 2024 May; 50(7):108428. PubMed ID: 38795679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.